Bernie Sanders says he will bring legislation to reduce prescription drug costs by 50%news2023-12-14T19:19:17+00:00December 14th, 2023|Endpoints News|
Fore! Amgen to become title sponsor of Irish Opennews2023-12-14T18:54:52+00:00December 14th, 2023|Endpoints News|
Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House saysnews2023-12-14T17:21:42+00:00December 14th, 2023|Endpoints News|
Publicis Health names new chief executive from its agency networknews2023-12-14T17:11:37+00:00December 14th, 2023|Endpoints News|
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug; BioNTech gears up to open first site in Africanews2023-12-14T16:55:53+00:00December 14th, 2023|Endpoints News|
‘Wonderful Christmas gift’: Fed’s surprise rate-cut plan springs hope of 2024 biotech market reboundnews2023-12-14T16:43:40+00:00December 14th, 2023|Endpoints News|
Playground raises $410M fund, Artis closes $200M as biology and tech VC convergence continuesnews2023-12-14T16:19:31+00:00December 14th, 2023|Endpoints News|
Did the FTC have a good reason to block the Sanofi-Maze deal?news2023-12-14T16:12:32+00:00December 14th, 2023|Endpoints News|
Apellis expects EU to reject eye drug; Terray teams up with Bristol Myers; Vandria raises $20Mnews2023-12-14T15:56:44+00:00December 14th, 2023|Endpoints News|
Novo Nordisk to boost oral GLP-1 manufacturing via $92.5M buy for Alkermes’ Ireland facilitynews2023-12-14T15:45:30+00:00December 14th, 2023|Endpoints News|
